Xarelto Lawsuit Plaintiffs Find Encouragement In Previous Pradaxa Settlement

BloodThinnerHelp.com reports on striking similarities between Pradaxa and Xarelto lawsuits that provides encouragement to plaintiffs in numerous Xarelto lawsuits as they await their day in court. Pradaxa was released in 2010 by Boehringer Ingelheim and shortly after its availability on the market it was hit with over 3,500 adverse event reports with over 750 of them being fatalities. The volume of adverse reports filed against Pradaxa quickly made it the subject of over 4,000 lawsuits. The drug's manufacturer, on the eve that the trials were to begin, settled all lawsuits with a $650 million settlement. Many Xarelto plaintiffs are hoping a similar result will ensue for them.

There have been over 2,800 federally-filed complaints against Xarelto. Due to the magnitude of the complaints and similarities of the allegations against the drug's manufacturers, Bayer AG and Janssen Pharmaceuticals, a subsidiary company of Johnson and Johnson Corporation, the United States Judicial Panel on Multidistrict Litigation (JPMDL) consolidated all cases to be heard together in a multidistrict litigation (MDL). Since the consolidation and in the month of August 2015 alone, the MDL expanded by 400 more cases and that number is expected to increase even further as Xarelto lawsuits continue to grow in both Louisiana and Pennsylvania.

The MDL is being overseen by the Honorable Judge Eldon Fallon in the Eastern District of Louisiana. The cases encompassed in the MDL are inching toward litigation. He had set a January 11, 2016, deadline for having 40 bellwether cases in a pool from which 4 would be selected for initial trials beginning in the spring of 2017.

It should also be noted that the 2,800 cases in the MDL are not the only ones being litigated. There is another group of 550 cases that have been consolidated in the Court of Common Pleas in Philadelphia, PA. The defendants in all these cases are Bayer and Janssen, as well.

The Osborne firm is offering free consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. Call (866) 425-8902 for more information about this release or the Xarelto litigation.